Intent to Sole Source - Amyloid PET

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 has issued a Special Notice announcing its intent to award a sole source contract to PETNET Solutions Inc. The contract pertains to the supply of AmyVid (Florbetapir F18 injection), a radiopharmaceutical used for Amyloid PET imaging at the James J. Peters VA Medical Center's Department of Nuclear Medicine. This notice, identified by the solicitation number 36C24225Q0593, was posted on May 1, 2025, with a response deadline of May 12, 2025. The procurement falls under NAICS category 325412 for Pharmaceutical Preparation Manufacturing and PSC category 6505 for Drugs and Biologicals. The primary goal of this contract is to provide veterans with timely and accurate diagnostic imaging to support clinical decision-making.

The Special Notice outlines a contract structure with a base period of 16 units and four subsequent periods of 25 units each. Interested parties are invited to submit an Expression of Interest (EOI) to Janelle Bonafede via email, with the government retaining sole discretion on whether to conduct a competitive procurement based on received responses. While the opportunity is marked as having no specific set-aside, potential contractors should carefully review the detailed requirements and submission guidelines. The sole source nature of the contract suggests that PETNET Solutions Inc. has been identified as the preferred vendor due to unique capabilities or qualifications in providing the specified radiopharmaceutical. Contractors interested in this opportunity should pay close attention to the May 12, 2025 deadline and be prepared to demonstrate compliance with all specified contract conditions and technical requirements for supplying the Amyloid PET imaging agent.